{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:47:04Z","timestamp":1789501624222,"version":"build-2803163510"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> International tourist travel has been increasingly steadily in recent years, and looks set to reach unprecedented levels in the coming decades. Among these travellers, an increasing proportion is aged over 60\u00a0years, and is healthy and wealthy enough to be able to travel. However, senior travellers have specific risks linked to their age, health and travel patterns, as compared to their younger counterparts.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We review here the risk of major vaccine-preventable travel-associated infectious diseases, and forms and efficacy of vaccination for these diseases.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Routine vaccinations are recommended for older persons, regardless of whether they travel or not (e.g., influenza, pneumococcal vaccines). Older individuals should be advised about the vaccines that are recommended for their age group in the framework of the national vaccination schedule. Travel-specific vaccines must be discussed in detail on a case-by-case basis, and the risk associated with the vaccine should be carefully weighed against the risk of contracting the disease during travel. Travel-specific vaccines reviewed here include yellow fever, hepatitis, meningococcal meningitis, typhoid fever, cholera, poliomyelitis, rabies, Japanese encephalitis, tick-borne encephalitis and dengue.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The number of older people who have the good health and financial resources to travel is rising dramatically. Older travellers should be advised appropriately about routine and travel-specific vaccines, taking into account the destination, duration and purpose of the trip, the activities planned, the type of accommodation, as well as patient-specific characteristics, such as health status and current medications.<\/jats:p>","DOI":"10.3389\/fragi.2021.677907","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T08:24:32Z","timestamp":1625819072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Vaccines and Senior Travellers"],"prefix":"10.3389","volume":"2","author":[{"given":"Fiona","family":"Ecarnot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"CD009029","DOI":"10.1002\/14651858.CD009029.pub2","article-title":"Vaccines for Preventing Enterotoxigenic Escherichia coli (ETEC) Diarrhoea","volume":"2013","author":"Ahmed","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/1469-0691.12518","article-title":"The Role of Vaccination in Preventing Pneumococcal Disease in Adults","volume":"20","author":"Aliberti","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding Immunosenescence and its Impact on Vaccination of Older Adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"E232","DOI":"10.1111\/j.1399-0012.2012.01629.x","article-title":"Estimating the Risks of Acquiring a Kidney Abroad: a Meta-Analysis of Complications Following Participation in Transplant Tourism","volume":"26","author":"Anker","year":"2012","journal-title":"Clin. Transpl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.vaccine.2008.01.019","article-title":"Cross-protection by MF59-Adjuvanted Influenza Vaccine: Neutralizing and Haemagglutination-Inhibiting Antibody Activity against A(H3N2) Drifted Influenza Viruses","volume":"26","author":"Ansaldi","year":"2008","journal-title":"Vaccine"},{"key":"B6","first-page":"361","article-title":"Frequency and Antimicrobial Susceptibility Patterns of Bacterial Pathogens Isolated from Septicemic Patients in Makkah Hospitals","volume":"27","author":"Asghar","year":"2006","journal-title":"Saudi Med. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1708-8305.2009.00307.x","article-title":"Hepatitis A Risk in Travelers","volume":"16","author":"Askling","year":"2009","journal-title":"J. Trav. Med"},{"key":"B8","unstructured":"Australian Public Assessment Report (AusPAR): Japanese Encephalitis Chimeric Virus2010"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/v13010096","article-title":"Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-\u03b3 and CLEC5A","volume":"13","author":"Azamor","year":"2021","journal-title":"Viruses"},{"key":"B10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.tmaid.2008.09.002","article-title":"Severe Sepsis and Septic Shock at the Hajj: Etiologies and Outcomes","volume":"7","author":"Baharoon","year":"2009","journal-title":"Trav. Med. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio Vaccination: Past, Present and Future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1016\/j.vaccine.2005.03.060","article-title":"Hepatitis A Virus Infection in the United States: Serologic Results from the Third National Health and Nutrition Examination Survey","volume":"23","author":"Bell","year":"2005","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/s1473-3099(16)00129-8","article-title":"Variable Influenza Vaccine Effectiveness by Subtype: a Systematic Review and Meta-Analysis of Test-Negative Design Studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/annalsats.201511-778fr","article-title":"Pneumococcal Vaccination Strategies. An Update and Perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann. ATS"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/nejmoa1903869","article-title":"Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/nejmoa1408544","article-title":"Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ajg.2012.7","article-title":"Viral Hepatitis in the Elderly","volume":"107","author":"Carrion","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B18","volume-title":"Chapter 2. Preparing International Travelers - Interactions between Travel Vaccines and Drugs. . Yellow Book (Health Information for International Travel)","year":"2020"},{"key":"B19","volume-title":"Chapter 4. Travel-Related Infectious Diseases - Meningococcal Disease. Yellow Book (Health Information for International Travel)","year":"2020"},{"key":"B20","first-page":"72","article-title":"Updated Recommendations for Use of Meningococcal Conjugate Vaccines \u2013 Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/1060028020935645","article-title":"High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults","volume":"55","author":"Chahine","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12890-016-0242-0","article-title":"A Systematic Review of the burden of Vaccine Preventable Pneumococcal Disease in UK Adults","volume":"16","author":"Chalmers","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1016\/j.vaccine.2019.08.016","article-title":"Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Adults \u226565 Years of Age: A Phase 3 Randomized Clinical Trial","volume":"37","author":"Chang","year":"2019","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects against Human Experimental Infection WithVibrio choleraeO1 El Tor","volume":"62","author":"Chen","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1080\/21645515.2016.1218098","article-title":"Tick-borne Encephalitis: What Travelers Should Know when Visiting an Endemic Country","volume":"12","author":"Chrdle","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3201\/eid2510.190271","article-title":"Global Epidemiology of Diphtheria, 2000-20171","volume":"25","author":"Clarke","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine Adjuvants: Putting Innate Immunity to Work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taz085","article-title":"Cholera in Travellers: a Systematic Review","volume":"26","author":"Connor","year":"2019","journal-title":"J. Trav. Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/cid\/ciz1034","article-title":"Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial","volume":"71","author":"Cowling","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.vaccine.2016.07.029","article-title":"Immunogenicity and Safety of the Inactivated Japanese Encephalitis Vaccine IXIARO in Elderly Subjects: Open-Label, Uncontrolled, multi-center, Phase 4 Study","volume":"34","author":"Cramer","year":"2016","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/14760584.2021.1889374","article-title":"Immunogenicity Following Revaccination or Sequential Vaccination with 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Older Adults and Those at Increased Risk of Pneumococcal Disease: a Review of the Literature","volume":"20","author":"Cripps","year":"2021","journal-title":"Expert Rev. Vaccin."},{"key":"B32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1708-8305.2006.00001.x","article-title":"Immunogenicity and Safety of a Virosomal Hepatitis A Vaccine (Epaxal) in the Elderly","volume":"13","author":"D'Acremont","year":"2006","journal-title":"J. Trav. Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40266-013-0065-0","article-title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial","volume":"30","author":"Dbaibo","year":"2013","journal-title":"Drugs Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1017\/s0950268818003473","article-title":"Pneumonia Hospitalisation and Case-Fatality Rates in Older Australians with and without Risk Factors for Pneumococcal Disease: Implications for Vaccine Policy","volume":"147","author":"Dirmesropian","year":"2019","journal-title":"Epidemiol. Infect."},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12979-020-00179-9","article-title":"The SENIEUR Protocol and the Efficacy of Hepatitis B Vaccination in Healthy Elderly Persons by Age, Gender, and Vaccine Route","volume":"17","author":"Edelman","year":"2020","journal-title":"Immun. Ageing"},{"key":"B36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2310\/7060.2005.12405","article-title":"Risk of Travel-Associated Typhoid and Paratyphoid Fevers in Various Regions","volume":"12","author":"Ekdahl","year":"2005","journal-title":"J. Trav. Med"},{"key":"B37","volume-title":"Epidemiological Situation of Tick-Borne Encephalitis in the European Union and European Free Trade Association Countries","year":"2012"},{"key":"B38","unstructured":"Summary of Opinion (Initial Authorisation): Vaxchora. Cholera Vaccine (Recombinant, Live, Oral). 30 January 2020. EMA\/CHMP\/33389\/2020. Committee for Medicinal Products for Human Use (CHMP)2020"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0169368","DOI":"10.1371\/journal.pone.0169368","article-title":"Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis","volume":"12","author":"Falkenhorst","year":"2017","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1708-8305.2008.00237.x","article-title":"Emergence ofSalmonella Paratyphi Aas a Major Cause of Enteric Fever: Need for Early Detection, Preventive Measures, and Effective Vaccines: Table 1","volume":"15","author":"Fangtham","year":"2008","journal-title":"J. Trav. Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"taaa052","DOI":"10.1093\/jtm\/taaa052","article-title":"Mitigating Yellow-Fever-Vaccine-Associated Viscerotropic Disease in Older Travellers","volume":"27","author":"Fletcher","year":"2020","journal-title":"J. Trav. Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa006","article-title":"Intradermal Rabies Pre-exposure Vaccination Schedules in Older Travellers: Comparison of Immunogenicity post-primary Course and post-booster","volume":"27","author":"Furuya-Kanamori","year":"2020","journal-title":"J. Trav. Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"A13","DOI":"10.1016\/j.vaccine.2019.07.036","article-title":"Cholera Surveillance and Estimation of burden of Cholera","volume":"38","author":"Ganesan","year":"2020","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1001638","DOI":"10.1371\/journal.pmed.1001638","article-title":"Yellow Fever in Africa: Estimating the burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data","volume":"11","author":"Garske","year":"2014","journal-title":"Plos Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0006951","DOI":"10.1371\/journal.pntd.0006951","article-title":"Rabies post-exposure Prophylaxis Started during or after Travel: A GeoSentinel Analysis","volume":"12","author":"Gautret","year":"2018","journal-title":"Plos Negl. Trop. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/j.ijid.2009.05.009","article-title":"Rabies Exposure in International Travelers: Do We Miss the Target?","volume":"14","author":"Gautret","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.vaccine.2011.11.007","article-title":"Rabies Vaccination for International Travelers","volume":"30","author":"Gautret","year":"2012","journal-title":"Vaccine"},{"key":"B48","unstructured":"Chapter 3: Infectious Diseases Related to Travel. Yellow Fever. CDC Health Information for International Travel\n            GershmanM. D.\n            StaplesJ. E.\n          2018"},{"key":"B49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1086\/431524","article-title":"Antibody Responses to Nasopharyngeal Carriage ofStreptococcus Pneumoniaein Adults: A Longitudinal Household Study","volume":"192","author":"Goldblatt","year":"2005","journal-title":"J. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding Immunosenescence to Improve Responses to Vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recomm. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the Management of Adults with Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia","volume":"171","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against Typhoid Fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tmaid.2013.07.003","article-title":"Tick-borne Encephalitis: a Disease Neglected by Travel Medicine","volume":"11","author":"Haditsch","year":"2013","journal-title":"Trav. Med. Infect. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5694\/mja2.50283","article-title":"Poliomyelitis Outbreak in Papua New Guinea: Health System and Health Security Implications for PNG and Australia","volume":"211","author":"Hall","year":"2019","journal-title":"Med. J. Aust."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taz062","article-title":"Severe Dengue in Travellers: Pathogenesis, Risk and Clinical Management","volume":"26","author":"Halstead","year":"2019","journal-title":"J. Trav. Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the Global burden of Endemic Canine Rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"Plos Negl. Trop. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese Encephalitis in Travelers from Non-endemic Countries, 1973-2008","volume":"82","author":"Hills","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12879-015-0803-5","article-title":"Etiology of Community-Acquired Pneumonia and Diagnostic Yields of Microbiological Methods: a 3-year Prospective Study in Norway","volume":"15","author":"Holter","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1017\/s0950268805004012","article-title":"A Longitudinal Household Study of Streptococcus Pneumoniae Nasopharyngeal Carriage in a UK Setting","volume":"133","author":"Hussain","year":"2005","journal-title":"Epidemiol. Infect."},{"key":"B62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11908-016-0540-y","article-title":"Human Rabies: a 2016 Update","volume":"18","author":"Jackson","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1586\/14760584.7.5.561","article-title":"Vaccination with Dukoralagainst Travelers' Diarrhea (ETEC) and Cholera","volume":"7","author":"Jelinek","year":"2008","journal-title":"Expert Rev. Vaccin."},{"key":"B64","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000504492","article-title":"Vaccines for Older Travelers","volume":"43","author":"Jilg","year":"2020","journal-title":"Interdiscip. Top. Gerontol. Geriatr."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/s0140-6736(17)32149-9","article-title":"Efficacy and Immunogenicity of a Vi-Tetanus Toxoid Conjugate Vaccine in the Prevention of Typhoid Fever Using a Controlled Human Infection Model of Salmonella Typhi: a Randomised Controlled, Phase 2b Trial","volume":"390","author":"Jin","year":"2017","journal-title":"The Lancet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"24268","DOI":"10.1073\/pnas.1909865116","article-title":"An Open challenge to advance Probabilistic Forecasting for Dengue Epidemics","volume":"116","author":"Johansson","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/648678","article-title":"Etiology of Community\u2010Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods","volume":"50","author":"Johansson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1016\/j.vaccine.2006.06.037","article-title":"Booster Vaccination in the Elderly: Their success Depends on the Vaccine Type Applied Earlier in Life as Well as on Pre-vaccination Antibody Titers","volume":"24","author":"Kaml","year":"2006","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0264-410x(94)90194-5","article-title":"Clinical and Serological Responses Following Primary and Booster Immunization with Salmonella typhi Vi Capsular Polysaccharide Vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ttbdis.2015.12.018","article-title":"The International Scientific Working Group on Tick-Borne Encephalitis (ISW TBE): Review of 17 Years of Activity and Commitment","volume":"7","author":"Kunze","year":"2016","journal-title":"Ticks Tick-borne Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijid.2015.07.003","article-title":"Safety and Immunogenicity of an Investigational Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Indian Subjects Aged 2 to 75 Years","volume":"38","author":"Lalwani","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1016\/j.vaccine.2015.08.037","article-title":"Considerations of Strategies to Provide Influenza Vaccine Year Round","volume":"33","author":"Lambach","year":"2015","journal-title":"Vaccine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4161\/hv.5.5.7575","article-title":"Antibodies to Tetanus, Diphtheria and Pertussis Among Healthy Adults Vaccinated According to the French Vaccination Recommendations","volume":"5","author":"Launay","year":"2009","journal-title":"Hum. Vaccin."},{"key":"B74","first-page":"244","article-title":"Age-related Risk of Adverse Events Following Yellow Fever Vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun. Dis. Intell. Q. Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1086\/322968","article-title":"Travel Vaccines and Elderly Persons: Review of Vaccines Available in the United States","volume":"33","author":"Leder","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ajem.2013.01.011","article-title":"Atypical Presentations of Dengue Disease in the Elderly Visiting the ED","volume":"31","author":"Lee","year":"2013","journal-title":"Am. J. Emerg. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/bf02850040","article-title":"Travelers' Diarrhea","volume":"23","author":"Leung","year":"2006","journal-title":"Adv. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"S552","DOI":"10.1093\/clinids\/11.supplement_3.s552","article-title":"Progress in Vaccines against Typhoid Fever","volume":"11","author":"Levine","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/jtm\/tay006","article-title":"Recent and Historical Trends in the Epidemiology of Japanese Encephalitis and its Implication for Risk Assessment in Travellers","volume":"25","author":"Lindquist","year":"2018","journal-title":"J. Trav. Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw045","article-title":"Adverse Event Reports Following Yellow Fever Vaccination, 2007-13","volume":"23","author":"Lindsey","year":"2016","journal-title":"J. Trav. Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4161\/hv.23267","article-title":"Effectiveness of the WC\/rBS Oral Cholera Vaccine in the Prevention of Traveler's Diarrhea","volume":"9","author":"L\u00f3pez-Gigosos","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"346","DOI":"10.5144\/0256-4947.2006.346","article-title":"Causes of Hospitalization of Pilgrims during the Hajj Period of the Islamic Year 1423 (2003)","volume":"26","author":"Madani","year":"2006","journal-title":"Ann. Saudi Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1016\/j.vaccine.2016.09.058","article-title":"Rabies Pre-exposure Prophylaxis Elicits Long-Lasting Immunity in Humans","volume":"34","author":"Mansfield","year":"2016","journal-title":"Vaccine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1532-5415.1997.tb01484.x","article-title":"Viral Hepatitis in Older Adults","volume":"45","author":"Marcus","year":"1997","journal-title":"J. Am. Geriatr. Soc."},{"key":"B85","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12955-019-1159-0","article-title":"A DELPHI Study on Aspects of Study Design to Overcome Knowledge Gaps on the burden of Disease Caused by Serogroup B Invasive Meningococcal Disease","volume":"17","author":"Marten","year":"2019","journal-title":"Health Qual. Life Outcomes"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm. Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1086\/323403","article-title":"Meningococcal Disease and Travel","volume":"34","author":"Memish","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1700636","DOI":"10.2807\/1560-7917.es.2018.23.34.1700636","article-title":"Interconnected Clusters of Invasive Meningococcal Disease Due to Neisseria Meningitidis Serogroup C ST-11 (Cc11), Involving Bisexuals and Men Who Have Sex with Men, with Discos and Gay-Venues Hotspots of Transmission, Tuscany, Italy, 2015 to 2016","volume":"23","author":"Miglietta","year":"2018","journal-title":"Euro Surveill."},{"key":"B89","doi-asserted-by":"publisher","first-page":"17-00278","DOI":"10.2807\/1560-7917.es.2018.23.6.17-00278","article-title":"Impact of Hepatitis B Vaccination on Acute Hepatitis B Epidemiology in European Union\/European Economic Area Countries, 2006 to 2014","volume":"23","author":"Miglietta","year":"2018","journal-title":"Euro Surveill."},{"key":"B90","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum. Vaccin."},{"key":"B91","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the Risks and Benefits of Yellow Fever Vaccination Including Some New Analyses","volume":"11","author":"Monath","year":"2012","journal-title":"Expert Rev. Vaccin."},{"key":"B92","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and Antibody Response, Including Antibody Persistence for 5 years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle\u2010Aged and Older Adults","volume":"201","author":"Musher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B93","first-page":"1","volume-title":"Viral Hepatitis in the Elderly. Geriatric Diseases: Evaluation and Management","author":"Nagaratnam","year":"2017"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.vaccine.2018.02.093","article-title":"Influenza Vaccine Effectiveness to Prevent Influenza-Related Hospitalizations and Serious Outcomes in Canadian Adults over the 2011\/12 through 2013\/14 Influenza Seasons: A Pooled Analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network)","volume":"36","author":"Nichols","year":"2018","journal-title":"Vaccine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/cid\/ciu002","article-title":"Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-Up in the CAPAMIS Study","volume":"58","author":"Ochoa-Gondar","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2310\/7060.2005.12604","article-title":"Combined Typhoid Fever and Hepatitis A Vaccine: Comparison of Immunogenicity and Safety to Concomitant Monovalent Vaccine over 3 Years","volume":"12","author":"Overbosch","year":"2005","journal-title":"J. Trav. Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1016\/j.vaccine.2015.06.046","article-title":"Prevention and Control of Meningococcal Outbreaks: The Emerging Role of Serogroup B Meningococcal Vaccines","volume":"33","author":"Oviedo-Orta","year":"2015","journal-title":"Vaccine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The Everchanging Epidemiology of Meningococcal Disease Worldwide and the Potential for Prevention through Vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J. Infect."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/microorganisms8101521","article-title":"Vaccines against Meningococcal Diseases","volume":"8","author":"Pizza","year":"2020","journal-title":"Microorganisms"},{"key":"B100","first-page":"829","article-title":"Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning Immunology from the Yellow Fever Vaccine: Innate Immunity to Systems Vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11684-018-0631-2","article-title":"Cholera: an Overview with Reference to the Yemen Epidemic","volume":"13","author":"Rabaan","year":"2019","journal-title":"Front. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fpubh.2019.00237","article-title":"Revisiting the Global Epidemiology of Cholera in Conjuction with the Genomics of Vibrio cholerae","volume":"7","author":"Ramamurthy","year":"2019","journal-title":"Front. Public Health"},{"key":"B104","doi-asserted-by":"publisher","first-page":"101876","DOI":"10.1016\/j.tmaid.2020.101876","article-title":"Immunogenicity and Safety of the Tick-Borne Encephalitis Vaccination (2009-2019): A Systematic Review","volume":"37","author":"Rampa","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/s1473-3099(20)30170-5","article-title":"Prevention of Yellow Fever in Travellers: an Update","volume":"20","author":"Reno","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.vaccine.2010.03.073","article-title":"Lack of Pneumococcal Carriage in the Hospitalised Elderly","volume":"28","author":"Ridda","year":"2010","journal-title":"Vaccine"},{"key":"B107","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/jtm\/tax026","article-title":"Guidelines for the Prevention and Treatment of Travelers' Diarrhea: a Graded Expert Panel Report","volume":"24","author":"Riddle","year":"2017","journal-title":"J. Trav. Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/rmhp.s130405","article-title":"Triptych of the Hermit Saints: Pneumococcal Polysaccharide Vaccines for the Elderly","author":"Rijkers","year":"2018","journal-title":"Rmhp"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e000359","DOI":"10.1136\/bmjresp-2018-000359","article-title":"Lifestyle and Comorbid Conditions as Risk Factors for Community-Acquired Pneumonia in Outpatient Adults (NEUMO-ES-RISK Project)","volume":"6","author":"Rivero-Calle","year":"2019","journal-title":"BMJ Open Respir. Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3109\/00365548.2014.887222","article-title":"Attack Rates of Dengue Fever in Swedish Travellers","volume":"46","author":"Rockl\u00f6v","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1016\/j.vaccine.2015.05.080","article-title":"Serological Response Following Re-vaccination with Salmonella typhi Vi-Capsular Polysaccharide Vaccines in Healthy Adult Travellers","volume":"33","author":"Roggelin","year":"2015","journal-title":"Vaccine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e27753","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia Following Yellow Fever Vaccination: a Prospective Controlled Cohort Study","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e2777","DOI":"10.1371\/journal.pntd.0002777","article-title":"Challenges in Dengue Fever in the Elderly: Atypical Presentation and Risk of Severe Dengue and Hospita-Acquired Infection","volume":"8","author":"Rowe","year":"2014","journal-title":"Plos Negl. Trop. Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1016\/j.vaccine.2015.10.055","article-title":"The Current Situation of Meningococcal Disease in Latin America and Updated Global Meningococcal Initiative (GMI) Recommendations","volume":"33","author":"S\u00e1fadi","year":"2015","journal-title":"Vaccine"},{"key":"B115","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","article-title":"Epidemiology of Acute and Chronic Hepatitis B and delta over the Last 5 Decades in Italy","volume":"20","author":"Sagnelli","year":"2014","journal-title":"Wjg"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3201\/eid1407.071412","article-title":"Seasonality, Annual Trends, and Characteristics of Dengue Among Ill Returned Travelers, 1997-2006","volume":"14","author":"Schwartz","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1016\/j.vaccine.2014.08.051","article-title":"Risk Groups for Yellow Fever Vaccine-Associated Viscerotropic Disease (YEL-AVD)","volume":"32","author":"Seligman","year":"2014","journal-title":"Vaccine"},{"key":"B118","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J. Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/17843286.2019.1662993","article-title":"Time of Administration of Rabies Immunoglobulins and Adequacy of Antibody Response upon post-exposure Prophylaxis: a Descriptive Retrospective Study in Belgium","volume":"76","author":"Soentjens","year":"2019","journal-title":"Acta Clinica Belgica"},{"key":"B120","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/cid\/ciy983","article-title":"Comparative Immunogenicity and Safety Trial of 2 Different Schedules of Single-Visit Intradermal Rabies Postexposure Vaccination","volume":"69","author":"Soentjens","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e868","DOI":"10.1016\/j.ijid.2010.03.017","article-title":"Safety and Immunogenicity of an Investigational Quadrivalent Meningococcal CRM197 Conjugate Vaccine, MenACWY-CRM, Compared with Licensed Vaccines in Adults in Latin America","volume":"14","author":"Stamboulian","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"B122","article-title":"Epidemiology of Tick-Borne Encephalitis (TBE) in International Travellers to Western\/Central Europe and Conclusions on Vaccination Recommendations","volume":"23","author":"Steffen","year":"2016","journal-title":"J. Trav. Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay046","article-title":"Travel Vaccine Preventable Diseases-Updated Logarithmic Scale with Monthly Incidence Rates","volume":"25","author":"Steffen","year":"2018","journal-title":"J. Trav. Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jtm.12171","article-title":"Vaccine\u2010Preventable Travel Health Risks: What Is the Evidence-What Are the Gaps?","volume":"22","author":"Steffen","year":"2015","journal-title":"J. Trav. Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2014.17006","article-title":"Traveler's Diarrhea","volume":"313","author":"Steffen","year":"2015","journal-title":"JAMA"},{"key":"B126","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/0264-410x(90)90213-6","article-title":"Risks of Hepatitis B for Travellers","volume":"8","author":"Steffen","year":"1990","journal-title":"Vaccine"},{"key":"B127","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jpids\/piv065","article-title":"The Health Burden of Invasive Meningococcal Disease: A Systematic Review","volume":"5","author":"Strifler","year":"2016","journal-title":"J. Ped Infect. Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","article-title":"Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead","volume":"71","author":"Syed","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/ene.13356","article-title":"EAN Consensus Review on Prevention, Diagnosis and Management of Tick-Borne Encephalitis","volume":"24","author":"Taba","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/infdis\/148.3.599","article-title":"Typhoid in the United States and the Risk to the International Traveler","volume":"148","author":"Taylor","year":"1983","journal-title":"J. Infect. Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/geriatrics6010013","article-title":"Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality","volume":"6","author":"Thomas","year":"2021","journal-title":"Geriatrics (Basel)"},{"key":"B132","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The Global burden of Typhoid and Paratyphoid Fevers: a Systematic Analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Typhoid","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B133","unstructured":"Global and Regional Tourism Performance2021"},{"key":"B134","first-page":"185","article-title":"Vaccines for Travelers","volume":"60","year":"2018","journal-title":"Med. Lett. Drugs Ther."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1080\/21645515.2015.1039758","article-title":"Characterization of an Age-Response Relationship to GSK's Recombinant Hepatitis B Vaccine in Healthy Adults: An Integrated Analysis","volume":"11","author":"Van Der Meeren","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1093\/milmed\/usz048","article-title":"Timing of Intradermal Rabies Pre-exposure Prophylaxis Injections: Immunological Effect on Vaccination Response","volume":"184","author":"Van Nieuwenhove","year":"2019","journal-title":"Mil. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/vbz.2016.2031","article-title":"Yellow Fever Remains a Potential Threat to Public Health","volume":"16","author":"Vasconcelos","year":"2016","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/nejmoa1411037","article-title":"Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Seroefficacy of Vi Polysaccharide-Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1038\/s41598-018-28111-8","article-title":"Age-related Differences in Humoral and Cellular Immune Responses after Primary Immunisation: Indications for Stratified Vaccination Schedules","volume":"8","author":"Wagner","year":"2018","journal-title":"Sci. Rep."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fimmu.2018.01035","article-title":"Impaired Immune Response to Primary but Not to Booster Vaccination against Hepatitis B in Older Adults","volume":"9","author":"Weinberger","year":"2018","journal-title":"Front. Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e82967","DOI":"10.1371\/journal.pone.0082967","article-title":"Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons","volume":"8","author":"Weinberger","year":"2013","journal-title":"PLoS One"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of Immune Responses to Vaccines in Elderly Persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased Antibody Titers and Booster Responses in Tick-Borne Encephalitis Vaccinees Aged 50-90 Years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","article-title":"The Epidemiology of Invasive Meningococcal Disease in EU\/EEA Countries, 2004-2014","volume":"35","author":"Whittaker","year":"2017","journal-title":"Vaccine"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tay057","article-title":"Serostatus-dependent Performance of the First Licensed Dengue Vaccine: Implications for Travellers","volume":"25","author":"Wilder-Smith","year":"2018","journal-title":"J. Trav. Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/qco.0b013e3282a64700","article-title":"Meningococcal Vaccine in Travelers","volume":"20","author":"Wilder-Smith","year":"2007","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B148","doi-asserted-by":"publisher","first-page":"482","DOI":"10.15585\/mmwr.mm6618a6","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine","volume":"66","author":"Wong","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"B149","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijid.2016.05.001","article-title":"Why is the yellow fever outbreak in Angola a 'threat to the entire world'?","volume":"48","author":"Woodall","year":"2016","journal-title":"International Journal of Infectious Diseases"},{"key":"B150","first-page":"477","article-title":"Cholera vaccines: WHO position paper \u2013 August 2017","volume":"92","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"B151","volume-title":"Global Hepatitis Report 2017","year":"2017"},{"key":"B152","unstructured":"List of Countries, Territories and Areas: Yellow Fever Vaccination Requirements and Recommendations; Malaria Situation; and Other Vaccination Requirements2019"},{"key":"B153","volume-title":"Polio Endgame Strategy 2019-2023: Eradication, Integration, Certification and Containment","year":"2019"},{"key":"B154","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2016.11.017","article-title":"Polio Vaccines: WHO Position Paper, March 2016-recommendations","volume":"35","year":"2017","journal-title":"Vaccine"},{"key":"B155","first-page":"201","article-title":"Rabies Vaccines: WHO Position Paper \u2013 April 2018","volume":"93","year":"2018","journal-title":"Wkly Epidemiol. Rec."},{"key":"B156","volume-title":"Statement of the Twenty-Seventh Polio IHR Emergency Committee","year":"2021"},{"key":"B157","first-page":"153","article-title":"Typhoid Vaccines: WHO Position Paper \u2013 March 2018","volume":"93","year":"2018","journal-title":"Wkly Epidemiol. Rec."},{"key":"B158","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid Vaccines: WHO Position Paper, March 2018 - Recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"B159","first-page":"409","article-title":"Yellow Fever in Africa and the Americas, 2017","volume":"93","year":"2018","journal-title":"Wkly Epidemiol. Rec."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.vaccine.2021.01.023","article-title":"Immunogenicity after Pre- and post-exposure Rabies Vaccination: A Systematic Review and Dose-Response Meta-Analysis","volume":"39","author":"Xu","year":"2021","journal-title":"Vaccine"},{"key":"B161","first-page":"442","article-title":"Yellow Fever in Africa and the Americas, 2016","volume":"92","year":"2017","journal-title":"Wkly Epidemiol. Rec."},{"key":"B162","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese Encephalitis","volume":"10","author":"Yun","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"B163","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The Global Impact of Vaccination against Hepatitis B: a Historical Overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/inf.0b013e31812565bc","article-title":"Revaccination with Locally-Produced Vi Typhoid Polysaccharide Vaccine Among Chinese School-Aged Children","volume":"26","author":"Zhou","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B165","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2310\/7060.2000.00054","article-title":"Risks of Hepatitis B in Travelers as Compared to Immunization Status","volume":"7","author":"Zuckerman","year":"2000","journal-title":"J. Trav. Med"}],"container-title":["Frontiers in Aging"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2021.677907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T08:25:03Z","timestamp":1625819103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2021.677907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":165,"alternative-id":["10.3389\/fragi.2021.677907"],"URL":"https:\/\/doi.org\/10.3389\/fragi.2021.677907","relation":{},"ISSN":["2673-6217"],"issn-type":[{"value":"2673-6217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"article-number":"677907"}}